CMG
57
-3
HUM
33
3
WHR
46
3
CMS
61
-6
NOC
35
-2
IFF
59
-3
PVH
27
3
VNO
57
5
RCL
76
3
HST
32
2
SHW
53
-6
IPG
53
3
ADI
60
5
HBI
31
-6
APA
32
2
NOV
53
-2
PEP
41
-3
AAPL
65
3
NVDA
61
5
CHRW
64
2
CMG
57
-3
HUM
33
3
WHR
46
3
CMS
61
-6
NOC
35
-2
IFF
59
-3
PVH
27
3
VNO
57
5
RCL
76
3
HST
32
2
SHW
53
-6
IPG
53
3
ADI
60
5
HBI
31
-6
APA
32
2
NOV
53
-2
PEP
41
-3
AAPL
65
3
NVDA
61
5
CHRW
64
2
Financhill
Back

Bread Financial Holdings Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
62

BFH
Bread Financial Holdings

Last Price:
$61.95
Seasonality Move:
3.18%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.33
Seasonality Move:
1.75%
Buy
62
Bread Financial Holdings (BFH) is a Buy

Is Bread Financial Holdings a Buy, Sell or Hold?

  • The current Bread Financial Holdings [BFH] share price is $62.41. The Score for BFH is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • BFH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BFH Stock Price Chart

What is Bread Financial Holdings's stock price today?

  • The Bread Financial Holdings share price today is $62.41
    The current trend is relatively stagnant and BFH is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

BFH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 51.5 Buy
Chaikin Money Flow: 308710 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (60.07 - 64.07) Buy
Bollinger Bands (100): (51.61 - 63.55) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

BFH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.85 Buy
20-day SMA: 62.77 Sell
50-day SMA: 62.36 Buy
200-day SMA: 52.24 Buy
8-day EMA: 61.93 Buy
20-day EMA: 62.09 Buy
50-day EMA: 61.16 Buy
200-day EMA: 53.17 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Bread Financial Holdings Earnings Growth & BFH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.77 per share, an increase next quarter of $0.48 per share, a decrease this year of $0.34 per share, and an increase next year of $2.56 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Bread Financial Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):